About Kamyar Bagheri
Kamyar Bagheri is a graduate in Medical Laboratory Sciences from Abadan University of Medical Sciences and recipient of the Outstanding Student Researcher Award (2025). His research interests include cancer immunology, translational oncology, hematologic malignancies, molecular oncology, and cellular immunotherapy. He has co-authored peer-reviewed publications in international journals covering cancer immunotherapy, molecular oncology, and related fields. He is particularly interested in translating discoveries in cancer biology into innovative therapeutic strategies through interdisciplinary research. His long-term goal is to contribute to the development of precision immunotherapies for hematologic and solid malignancies.
Intro Content
Harnessing the potential of CAR-NK cell therapy in gastrointestinal cancers: From bench to bedside
Gastrointestinal cancers are highly lethal and often refractory to nonspecific chemo‑radiotherapy. Engineered immunotherapies, notably CAR‑NK cells, offer targeted, safer, allogeneic treatment with innate CAR‑independent killing.
Popular Content
The safety and efficacy of bispecific T-cell engagers (TCEs) in patients with glioma
Glioblastoma (GBM) is a highly aggressive brain tumor with limited treatment options and poor prognosis. Bispecific T-cell engagers (TCEs) offer a promising immunotherapy approach by redirecting T cells to tumor antigens, and this review highlights their progress and challenges in glioma treatment.
Recent Comments
Excellent Job!
A rigorous, translationally important study: the activation/rest model isolates permanent senescence distinct from exhaustion and reveals CSD‑dependent vulnerabilities—MYC‑linked senescence in BBζ versus adaptive responses in 28ζ—pointing to CSD‑guided engineering and senescence‑targeted strategies to improve CAR‑T durability.